European equities trading in the US as American depositary receipts were sharply higher late Monday morning, as the S&P Europe Select ADR Index rose 1.6% to 1,315.5.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and 3D printer company Materialise (MTLS), which climbed 20% and 6% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and semiconductor company Sequans Communications (SQNS) that increased almost 5% and 3%, respectively.
The worst decliners in continental Europe were pharmaceutical company Novo Nordisk (NVO) and consumer goods giant Unilever (UL) losing roughly 2% each. They were followed by pharmaceutical company Ascendis Pharma (ASND) and Natuzzi (NTZ), which were down nearly 2% and 1%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics, (AKTX) and alcoholic beverage company Diageo (DEO), gaining 6% and 3%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and insurance firm Prudential (PUK), which were up 2.6% and 2.9%, respectively.
The worst decliners in the UK and Ireland were biopharmaceutical company TC Biopharm (TCBP) and communications company WPP (WPP), shedding 11% and 2% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL), which dropped 2.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。